Results 91 to 100 of about 32,075 (207)
Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates [PDF]
, 2009 The in vitro activity of iclaprim, a novel diaminopyrimidine derivative, was evaluated against 5,937 recent gram-positive clinical isolates collected in the United States and Europe.
Fritsche, Thomas R. +2 more
core +1 more source
Novel and emerging antimicrobial strategies in the management of oral infections
Periodontology 2000, EarlyView.Abstract Background Antibiotics marked a pivotal turning point in human civilization, enhancing social interactions and extending human life expectancy. In addition to their success in treating systemic infectious diseases, they have significantly improved periodontal treatment outcomes as an adjunct therapy.
Ozge Unlu, Nil Yakar, Alpdogan Kantarci
wiley +1 more source
Transplant Infectious Disease, EarlyView.This study analyzed outcomes of an early Mollicute (Mycoplasma hominis and Ureaplasma spp.) screening protocol using BAL PCR with preemptive treatment and ammonia monitoring in lung transplant recipients. This appears to be a practical and reasonably effective approach for preventing early Mollicute infection and hyperammonemia syndrome.
Lalithaa Thirunavukarasu Murugan +5 more
wiley +1 more source
In vitro activities of tigecycline combined with other antimicrobials against multiresistant Gram-positive and Gram-negative pathogens [PDF]
, 2017 Objectives To test the activity of tigecycline combined with 16 antimicrobials in vitro against 22 Gram-positive and 55 Gram-negative clinical isolates. Methods Antibiotic interactions were determined by chequerboard and time-kill methods.
Entenza, José M. +3 more
core
Ocular toxoplasmosis: an update and review of the literature [PDF]
, 2009 Ocular toxoplasmosis is the most common cause of posterior uveitis worldwide. The infection can be acquired congenitally or postnatally and ocular lesions may present during or years after the acute infection occur.
Belfort, Rubens Junior +6 more
core +4 more sources
MicrobiologyOpen, Volume 15, Issue 3, June 2026.In Belize, a 7‐year nationwide study reveals a sharp rise in antimicrobial resistance in surgical infections. ESBL‐producing bacteria more than doubled to > 45%, with critical treatment gaps and geographic hotspots identified. Sentinel pan‐drug‐resistant cases and a correlation between antibiotic use and resistance underscore the urgent need for ...
Innocent E. Nwachukwu +5 more
wiley +1 more source
A Quantitative Model to Estimate Drug Resistance in Pathogens
Journal of Fungi, 2016 Pneumocystis pneumonia (PCP) is an opportunistic infection that occurs in humans and other mammals with debilitated immune systems. These infections are caused by fungi in the genus Pneumocystis, which are not susceptible to standard antifungal agents ...
Frazier N. Baker +2 more
doaj +1 more source
ChemistryOpen, Volume 15, Issue 6, June 2026.Modified biochar is an effective adsorbent for removing pharmaceutical contaminants from water. Physical and chemical modifications enhance its surface area, porosity, and functionality, enabling multiple adsorption mechanisms. These synergistic interactions improve removal efficiency.
Ebrahim Tangestani +3 more
wiley +1 more source
Frontiers in MedicineNocardia bacteremia is a rare but life-threatening opportunistic infection associated with high mortality rates. Early diagnosis and prompt initiation of appropriate treatment are crucial for improving patient outcomes.
Ning Du +6 more
doaj +1 more source
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT Rituximab is an anti‐CD20 monoclonal antibody used in autoimmune diseases, including glomerular diseases. The FCGR2A (rs1801274) and FCGR3A (rs396991) variants have been suggested to affect rituximab efficacy; this study evaluates their impact on rituximab efficacy in glomerular diseases.
María Larrosa‐García +10 more
wiley +1 more source